Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
Sponsor: Sanofi
Summary
Primary objective: \- Describe the characteristics of enrolled severe asthma patients Secondary objectives: * Assess the control of asthma under dupilumab (Dupixent®) treatment until 1 year * Assess the clinical objectives of the asthma care * Assess comorbidities associated with Type 2 inflammation * Assess safety during the year of treatment
Official title: National, Multicentre, Non-interventional, Prospective and Retrospective Study in Adolescent Patients With Severe Uncontrolled Asthma Starting Treatment With Dupilumab (Dupixent®)
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
OBSERVATIONAL
Enrollment
105
Start Date
2021-11-04
Completion Date
2025-03-03
Last Updated
2026-06-05
Healthy Volunteers
No
Conditions
Locations (1)
Investigational site France
France, France